The role of mesenchymal stem cells in the treatment and pathogenesis of psoriasis

Cytokine. 2024 Oct:182:156699. doi: 10.1016/j.cyto.2024.156699. Epub 2024 Jul 20.

Abstract

Psoriasis, a prevalent inflammatory skin condition impacting millions globally, continues to pose treatment challenges, despite the availability of multiple therapies. This underscores the demand for innovative treatments. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic option due to their capacity to modulate the immune system and facilitate tissue healing. Recent research indicates that MSCs don't just work through direct cell-to-cell interactions but also release extracellular vesicles (EVs), containing various bioactive substances like proteins, lipids, and nucleic acids. This article explores our current knowledge of psoriasis's origins and the potential utilization of MSCs and their EVs, particularly exosomes, in managing the condition. Additionally, we delve into how MSCs and EVs function in therapy, including their roles in regulating immune responses and promoting tissue repair. Lastly, we discuss the obstacles and opportunities associated with translating MSC-based treatments for psoriasis into clinical practice.

Keywords: Autoimmune diseases; Extracellular vesicles; Immunomodulation; Mesenchymal stem cells; Psoriasis.

Publication types

  • Review

MeSH terms

  • Animals
  • Exosomes* / metabolism
  • Extracellular Vesicles / metabolism
  • Humans
  • Mesenchymal Stem Cell Transplantation* / methods
  • Mesenchymal Stem Cells* / immunology
  • Mesenchymal Stem Cells* / metabolism
  • Psoriasis* / therapy